TVTX
Travere Therapeutics, Inc.Healthcare$30.44
▼ Bearish
Mkt Cap: $2.81B|Float: 91.2M|SI: 14.7%|DTC: 9.1
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
47.0%
52W Range
$13-$42
ATR(14)
$1.31
Exp. Move
±37.6%
P/C Ratio
0.71
Earnings
Apr 30
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
TVTX Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $1.8M
- Max Pain
- $27.50
- Expected Move
- ±37.6%
- Put/Call OI
- 0.71
- Net Premium
- $-0.2M
- Spot Price
- $30.44
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$11.45 | ±37.6% | $18.99 | $41.89 |
| 2026-05-15 | 43 | ±$5.50 | ±18.1% | $24.94 | $35.94 |
| 2026-06-18 | 77 | ±$16.00 | ±52.6% | $14.44 | $46.44 |
| 2026-09-18 | 169 | ±$8.35 | ±27.4% | $22.09 | $38.79 |
| 2026-12-18 | 260 | ±$17.75 | ±58.3% | $12.69 | $48.19 |
| 2027-01-15 | 288 | ±$18.45 | ±60.6% | $11.99 | $48.89 |
Explore TVTX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.